Mayne Pharma to invest $65m in major manufacturing expansion in North Carolina

SourceMetrics Inc.
Date Published08/27/2015
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Mayne Pharma
Type of work Manufacturing
Reshoring category:Transplant
Total number of jobs (added or to be added):110
Year reshoring announced:2015
Year reshoring implemented or to be implemented:2018
Capital investment ($):65
Country(ies) from which reshored:Australia
City reshored to:Greenville
State(s) reshored to:NC
If relevant, work nearshored to:-
Product(s) reshoredPharmaceuticals, oral-dose
What domestic positive factors made reshoring more attractive?Eco-system synergies, Government Incentives, Under-utilized capacity
Find Reshoring Articles